Need all Congresses? Press Enter for expanded federal results.

Drug safety, medical device, and laboratory regulation

Track this topic across federal Congress bills, then open each bill page for full context and activity.

Matched bills
173
Coverage
110th-119th
Current view
115th Congress
Congress Filter
Switch views to focus this topic by Congress.
Bills In This Topic
173 results.
Click any row to open the federal bill page.
Bill Title Congress Status Action Date
HR 7369
DEA Notification Act of 2018
115th Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. December 20, 2018
HR 7348
Affordable Drug Manufacturing Act of 2018
115th Referred to the House Committee on Energy and Commerce. December 19, 2018
HR 7339
Medicare for America Act of 2018
115th Referred to the Committee on Ways and Means, and in addition to the Committees on Energy and Commerce, Education and the Workforce, Natural Resources, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. December 19, 2018
HR 7328
Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018
115th Received in the Senate. December 20, 2018
HR 7324
Preserving Access to Orphan Drugs Act of 2018
115th Referred to the Subcommittee on Health. January 2, 2019
HR 7251
Hatch-Waxman Integrity Act of 2018
115th Referred to the Committee on Energy and Commerce, and in addition to the Committee on Financial Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. December 11, 2018
HR 6903
Safe Cosmetics and Personal Care Products Act of 2018
115th Referred to the Committee on Energy and Commerce, and in addition to the Committee on Education and the Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. September 26, 2018
HR 6878
Eliminating Kickbacks in Recovery Act of 2018
115th Referred to the House Committee on the Judiciary. September 25, 2018
HR 6818
Clean Water Infrastructure Act
115th Referred to the House Committee on Energy and Commerce. September 13, 2018
HR 6801
RaD Fund Act of 2018
115th Referred to the House Committee on Energy and Commerce. September 13, 2018
HR 6717
Depression Side Effect Labeling Awareness Act of 2018
115th Referred to the House Committee on Energy and Commerce. September 6, 2018
HR 6688
ALERT Act of 2018
115th Referred to the Subcommittee on Health. August 31, 2018
HR 6576
Drug-Price Transparency in Communications Act
115th Referred to the Subcommittee on Health. July 27, 2018
HR 6562
FORWARD Act of 2018
115th Referred to the Subcommittee on Health. July 27, 2018
HR 6505
Medicare Negotiation and Competitive Licensing Act of 2018
115th Referred to the Subcommittee on Health. August 3, 2018
HR 6495
Marijuana Data Collection Act
115th Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations. October 1, 2018
HR 6478
Biosimilars Competition Act of 2018
115th Referred to the Subcommittee on Health. July 27, 2018
HR 6294
REVAMP Act
115th Referred to the House Committee on Energy and Commerce. June 28, 2018
HR 6205
DOSE Act
115th Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations. August 2, 2018
HR 6142
Reducing Drug Waste Act of 2018
115th Referred to the House Committee on Energy and Commerce. June 19, 2018
HR 6133
Informing Opioid Prescribing Through Evidence-Based Guidelines Act of 2018
115th Referred to the House Committee on Energy and Commerce. June 19, 2018
HR 5997
Ensuring Patient Access to Critical Breakthrough Products Act of 2018
115th Referred to the Subcommittee on Health. June 8, 2018
HR 5867
Reducing Drug Waste Act of 2018
115th Referred to the House Committee on Energy and Commerce. May 17, 2018
HR 5865
Addiction Prevention and Responsible Opioid Practices Act
115th Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations. July 24, 2018
HR 5811
Long-Term Opioid Efficacy Act of 2018
115th Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions. June 20, 2018
HR 5806
21st Century Tools for Pain and Addiction Treatment Act
115th Ordered to be Reported by the Yeas and Nays: 31 - 23. May 17, 2018
HR 5803
SAFETY Act of 2018
115th Referred to the House Committee on Energy and Commerce. May 15, 2018
HR 5782
Opioid Crisis Accountability Act of 2018
115th Referred to the Subcommittee on Health. May 31, 2018
HR 5752
Stop Illicit Drug Importation Act of 2018
115th Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions. June 14, 2018
HR 5739
Prescription Drug and Medical Device Price Review Board Act of 2018
115th Referred to the Subcommittee on Health. May 25, 2018
HR 5687
SOUND Disposal and Packaging Act
115th Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions. June 20, 2018
HR 5634
Medical Cannabis Research Act of 2018
115th Ordered to be Reported (Amended) by Voice Vote. September 13, 2018
HR 5599
Animal Health and Innovation Act of 2018
115th Referred to the House Committee on Energy and Commerce. April 24, 2018
HR 5591
SHIELDS Act
115th Referred to the Subcommittee on Military Personnel. April 25, 2018
HR 5568
National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act of 2018
115th Referred to the House Committee on Energy and Commerce. April 18, 2018
HR 5554
Animal Drug and Animal Generic Drug User Fee Amendments of 2018
115th Became Public Law No: 115-234. August 14, 2018
HR 5548
Water, Cosmetics, and Unwanted Pharmaceuticals Study Act
115th Referred to the House Committee on Energy and Commerce. April 18, 2018
HR 5473
Better Pain Management Through Better Data Act of 2018
115th Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions. June 13, 2018
HR 5333
Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2018
115th Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 518. July 17, 2018
HR 5298
Modernizing Drug Enforcement Act of 2018
115th Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations. April 30, 2018